Interaction between O-GlcNAc Modification and Tyrosine Phosphorylation of Prohibitin: Implication for a Novel Binary Switch by Ande, Sudharsana R. et al.
Interaction between O-GlcNAc Modification and Tyrosine
Phosphorylation of Prohibitin: Implication for a Novel
Binary Switch
Sudharsana R. Ande
1, Saby Moulik
2, Suresh Mishra
1,2*
1Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada, 2Department of Physiology, University of Manitoba, Winnipeg, Manitoba,
Canada
Abstract
Prohibitin (PHB or PHB1) is an evolutionarily conserved, multifunctional protein which is present in various cellular
compartments including the plasma membrane. However, mechanisms involved in various functions of PHB are not fully
explored yet. Here we report for the first time that PHB interacts with O-linked b-N-acetylglucosamine transferase (O-GlcNAc
transferase, OGT) and is O-GlcNAc modified; and also undergoes tyrosine phosphorylation in response to insulin. Tyrosine
114 (Tyr114) and tyrosine 259 (Tyr259) in PHB are in the close proximity of potential O-GlcNAc sites serine 121 (Ser121) and
threonine 258 (Thr258) respectively. Substitution of Tyr114 and Tyr259 residues in PHB with phenylalanine by site-directed
mutagenesis results in reduced tyrosine phosphorylation as well as reduced O-GlcNAc modification of PHB. Surprisingly, this
also resulted in enhanced tyrosine phosphorylation and activity of OGT. This is attributed to the presence of similar tyrosine
motifs in PHB and OGT. Substitution of Ser121 and Thr258 with alanine and isoleucine respectively resulted in attenuation
of O-GlcNAc modification and increased tyrosine phosphorylation of PHB suggesting an association between these two
dynamic modifications. Sequence analysis of O-GlcNAc modified proteins having known O-GlcNAc modification site(s) or
known tyrosine phosphorylation site(s) revealed a strong potential association between these two posttranslational
modifications in various proteins. We speculate that O-GlcNAc modification and tyrosine phosphorylation of PHB play an
important role in tyrosine kinase signaling pathways including insulin, growth factors and immune receptors signaling. In
addition, we propose that O-GlcNAc modification and tyrosine phosphorylation is a novel previously unidentified binary
switch which may provide new mechanistic insights into cell signaling pathways and is open for direct experimental
examination.
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Introduction
Prohibitin (PHB, also known as PHB1) and its homologue
PHB2 are evolutionarily conserved proteins and have been shown
to be involved in cell cycle progression, cell differentiation, gene
transcription and mitochondrial functions [1]. However, mecha-
nisms involved in various functions of PHBs are poorly
characterized. PHB has been reported to be present in the plasma
membrane especially in the lipid rafts of B cells, Caco-2 cells (a
model intestinal epithelial cell), adipocytes, and endothelial cells of
adipose tissue vasculature [1–5]. Lipid rafts has been known to
serve as platforms for receptor tyrosine kinase signaling including
insulin and B cell receptor signaling [6]. This involves tyrosine
phosphorylation of various signaling intermediates and tyrosine
phosphorylation dependent protein-protein interactions [7,8].
PHB has been shown to be required for Ras-induced Raf-MEK-
ERK activation in epidermal growth factor receptor signaling
pathway however mechanism involved in this process remains to
be determined [9]. Central and C-terminus part of PHB contain
tyrosine residues (Tyr114 and Tyr259) which exist within a motif
similar to tyrosine known to be phosphorylated in the epidermal
growth factor and insulin receptors [10], in beta integrins [11] and
in B cell receptors [12]. Phosphorylation of tyrosine residues
within these motifs are known to be recognized by phospho
tyrosine binding (PTB) domain of signaling proteins [13,14].
Tyr114 and Tyr259 residues in PHB are highly conserved across
species suggesting a functional role for these residues [1].
In addition to tyrosine phosphorylation, O-GlcNAc (O-linked b-
N-acetylglucosamine) modification of tyrosine kinase signaling
intermediates by O-GlacNAc transferase (OGT) has been shown
to play a regulatory role in receptor tyrosine kinase signaling
pathways [15–16]. OGT transfers N-acetylglucosamine from
UDP-GlcNAc to a hydroxyl oxygen of serine or threonine in a
b confirmation (b-O-glycosylation) [17]. OGT itself undergo
tyrosine phosphorylation which enhances OGT activity [15]. In
many proteins a yin-yang relationship (i.e. same serine/threonine
residues are subjected to both phosphorylation and O-GlcNAc
modification under different conditions) exists [18–20], therefore it
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because both modifications occur at the same residue. It is not
known whether tyrosine phosphorylation can also influence O-
GlcNAc modification and vice versa. Here we report that PHB
interact with OGT both in vivo and in vitro and is an O-GlcNAc
modified protein. In addition, we provide data which suggests that
O-GlcNAc modification and tyrosine phosphorylation in a protein
interact with each other. Implication of this study extends beyond
protein specific binary switch and offers new mechanistic insights
into tyrosine kinase signaling pathways.
Results
PHB interacts with OGT and is an O-GlcNAc modified
Because PHB and OGT both interact with insulin receptor and
undergo tyrosine phosphorylation [15,21], we examined whether
PHB could interact with OGT. In co-immunoprecipitation assays,
we found that both PHB and OGT co-immunoprecipitated with
each other in response to insulin (Fig. 1A). A very weak signal was
observed in the absence of insulin. This is further confirmed by in
situ co-localization of PHB and OGT using confocal microscopy
(Fig. 1B). This prompted us to examine whether PHB is subjected
to modification by OGT. Cell lysates prepared from three
different cell lines were analyzed by SDS-PAGE and processed
for immunoblotting using monoclonal anti-O-GlcNAc antibody.
Multiple O-GlcNAc modified protein bands were observed around
expected ,30 kDa PHB band. To confirm whether one of them is
PHB, membranes were stripped and reprobed with anti-PHB
antibody. Indeed one of the O-GlcNAc modified band exactly
coincided with PHB band in overlay suggesting that PHB
undergoes O-GlcNAc modification (Fig. 1C). Recombinant His-
PHB was also detected by anti-O-GlcNAc antibody. A similar
result was found when PHB was immunoprecipitated and
analyzed by gel-electrophoresis and immunoblotting using mono-
clonal anti-O-GlcNAc antibody (Fig. 1C). O-GlcNAc modification
of PHB was further confirmed by metabolic labeling of PHB with
tetraacetylated azide-modified N-acetylglucosamine (GlcNAz) in
C2C12 and NIH-3T3 cell lines and subsequent tagging with biotin
alkyne (Fig. 1D). In both cell lines used, PHB was found labeled
with GlcNAz sugar suggesting that O-GlcNAc modification of
PHB is not cell specific (Fig. 1D). In insulin treated cells a more
intense O-GlcNAc modified PHB band was observed in compar-
ison to untreated controls suggesting that insulin facilitates O-
GlcNAc modification of PHB. A similar result was found with
RINm5F cells (data not shown). These data together suggest that
PHB interacts with OGT and is an O-GlcNAc modified protein.
O-GlcNAc modification and tyrosine phosphorylation
affects each other
Because PHB undergoes both O-GlcNAc modification and
tyrosine phosphorylation, we asked the question whether these
modifications occur in neighboring residues and affect each other.
Analysis of PHB protein sequence by Human Protein Reference
Database, NetPhos and Scansite servers identified Tyr114 and
Tyr259 as potential sites of phosphorylation. Interestingly two (i.e.
Ser121 and Thr258) out of three potential O-GlcNAc sites (i.e.
Ser101, Ser121 and Thr258) predicted (discussed later) in PHB are
either adjacent to or in the close proximity of tyrosine
phosphorylation sites (Tyr114 and Tyr259). Therefore, we used
two synthetic peptides (Pep I - Biotin-
105RIFTSIGEDYDERVLP-
SIT
123-NH2 and Pep II - Biotin-
250QLSRSRNITYLPAGQ-
SVLL
268-NH2) biotinylated at the N-terminus and amidated at
the C-terminus spanning tyrosine phosphorylation and O-GlcNAc
modification sites in PHB. In in vitro kinase assays using catalytic
domain of insulin receptor (Upstate Biotechnology, NY, USA) and
ATP (Sigma, ON, Canada) and subsequent analysis with
immunoblotting we found that both peptides were phosphorylated
at tyrosine residue (Fig. 2A). To determine the potential O-GlcNAc
modification of tyrosine neighboring residues, biotinylated syn-
thetic peptides of PHB were incubated with immunoprecipitated
OGT and UDP-GlcNAc and subsequently analyzed with gel-
electrophoresis and immunoblotting. O-GlcNAc modification was
detected by immunoblotting using monoclonal anti O-GlcNAc
antibody (Fig. 2A) suggesting that they had undergone O-GlcNAc
modification. Because both peptides contain multiple serine and/
or threonine residues therefore O-GlcNAc modification of these
peptides at sites other than Ser121 and Thr258 may not be ruled
out.
To determine whether tyrosine phosphorylation modulates O-
GlcNAc modification we used biotinylated synthetic peptides with
a phosphate group attached to Tyr114 and Tyr259 in in vitro O-
GlcNAc assays. Presence of phosphate at tyrosine residues (Tyr114
and Tyr259) significantly enhanced the O-GlcNAc modification of
both peptides in comparison to non-phosphorylated control
peptides (Fig. 2B). Similar results were found when peptides were
phosphorylated using catalytic domain of insulin receptor (data not
shown). This is in contrast to yin-yang sites in which phosphor-
ylation at serine or threonine residues has been shown to be
associated with down regulation of O-GlcNAc modification and
vice versa [18–19]. To determine whether O-GlcNAc modification
affect tyrosine phosphorylation, biotinylated peptides (Pep I and
Pep II) were immobilized on streptavidin-agarose beads and
processed for in vitro O-GlcNAc assays using immunoprecipitated
OGT and UDP-GlcNAc. After washing, immobilized control
peptides (without any modification) and OGT induced O-GlcNAc
modified peptides were used for in vitro kinase assays using catalytic
domain of insulin receptor and ATP. Interestingly tyrosine
phosphorylation of these peptides was attenuated in the presence
of O-GlcNAc modification in comparison to non-glycosylated
control peptides (Fig. 2B). Taken together, these results suggest
that tyrosine phosphorylation enhances O-GlcNAc modification
whereas O-GlcNAc modification attenuates tyrosine phosphoryla-
tion at least in these peptides.
Loss of tyrosine phosphorylation in PHB enhances OGT
activity
To determine whether tyrosine phosphorylation and O-GlcNAc
modification of PHB interact within cells in the same manner as in
an in vitro assay; Tyr114, Ser121, Thr258 and Tyr259 were
substituted with phenylalanine, alanine, isoleucine and phenylal-
anine respectively by site-directed mutagenesis. Cells were
transfected with wild type and PHB mutant vectors. After insulin
treatment, PHB was immunoprecipitated and subsequently
analyzed with gel electrophoresis and immunoblotting. An
attenuation of tyrosine phosphorylation and O-GlcNAc modifica-
tion was observed in Tyr114Phe and Tyr259Phe PHB mutants in
comparison to wild type PHB in response to insulin (Fig. 2C)
suggesting that Tyr114 and Tyr259 in PHB undergo phosphor-
ylation in response to insulin and phosphorylation at these tyrosine
residues facilitates O-GlcNAc modification of PHB. While
substitution of Ser121 and Thr258 in PHB with alanine and
isoleucine respectively resulted in reduced O-GlcNAc modification
and increased tyrosine phosphorylation of PHB in response to
insulin (Fig. 2D) suggesting that O-GlcNAc modification attenuates
tyrosine phosphorylation of PHB. No difference was observed in
the absence of insulin (data not shown). Surprisingly a significant
up regulation of O-GlcNAc modification of some proteins in the
molecular weight range of ,50–100 kDa was also observed in
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Tyr259Phe PHB mutants (Fig. 3A). Next we sought to know
whether OGT itself is O-GlcNAc modified in cells transfected with
tyrosine PHB mutants. To determine this, OGT was immuno-
precipitated from untreated and insulin treated cells transfected
with PHB tyrosine mutants and analyzed by immunoblotting using
anti-O-GlcNAc antibody. An enhanced O-GlcNAc modification of
OGT was observed in cells transfected with PHB mutants in
comparison to wild type PHB in response to insulin only (Fig. 3B).
To gain further insight into the mechanism involved, PHB
sequence was analyzed with pBLAST search for any potential
homology with OGT family members. Interestingly two OGT
family members (UDP-N-acetyl-alpha-D-galactosamine: polypep-
tide N-acetylgalactosaminyltransferase 13 (Accession no. XP_
515839.1) and b-1,4-N-acetyl-galactosaminyl transferase 2 (Acces-
sion no. XP_548187.2) were identified with significant homology
with PHB (Fig. 4A). Although it was very tempting to jump to the
conclusion that PHB may have O-GlcNAc activity, however in
both proteins PHB homologous region was not in the catalytic
domain of these two enzymes indicating that it is unlikely that
PHB has OGT activity. We speculate that these homologous
regions in PHB and OGT family members are targeted by or
interact with similar set of proteins and may have regulatory
functions. In addition, homologous tyrosine motifs were also found
between human OGT and central part of PHB containing Tyr114
and neighboring O-GlcNAc site that is Ser121; as well as between
Oryza OGT and C-terminus part of PHB containing Tyr259 and
neighboring O-GlcNAc site that is Thr258 (Fig. 4A). Subsequently
we narrowed down our search to limit it to phospho tyrosine
motifs in PHB and OGT family members. Interestingly pBLAST
search for phospho tyrosine motifs in PHB limited to similar motifs
in OGT family members revealed that tyrosine motifs in PHB
containing Tyr114 and Tyr259 are very similar to tyrosine motifs
present in various members of OGT family members (Fig. 4)
suggesting that they may be targeted by similar tyrosine kinases
and upon phosphorylation may interact with similar proteins.
Recently OGT has been reported to interact with insulin receptor
and insulin receptor induced tyrosine phosphorylation of OGT
enhances OGT activity [15]. Therefore, we examined the tyrosine
phosphorylation levels of OGT in cells co-transfected with OGT
and PHB vectors in response to insulin. An increase in tyrosine
phosphorylation of OGT was found with no change in OGT
protein levels in cells transfected with PHB mutants (Fig. 3C). To
ascertain whether increased O-GlcNAc modification of some
proteins in the case of PHB mutants (Ty114Phe and Tyr259Phe) is
due to increased OGT activity, in vitro O-GlcNAc assays were
performed using immunoprecipitated OGT from insulin treated
cells co-transfected with OGT and wild type PHB or tyrosine
(Tyr114 and Tyr259) mutant-PHB. An increase in OGT enzyme
activity was found consistent with increased tyrosine phosphory-
lation of OGT in comparison with controls (Fig. 3C). These data
together suggests that increased O-GlcNAc modification of some
proteins in cells transfected with PHB mutants were due to
increased activity of OGT, most probably as a result of increased
tyrosine phosphorylation of OGT.
O-GlcNAc modification and tyrosine phosphorylation – A
novel binary switch
To gain further insight into a potential global regulatory role of
tyrosine phosphorylation on O-GlcNAc modification and vice versa,
we analyze motifs around known sites of O-GlcNAc modified
proteins, and known sites of phospho tyrosine containing proteins
which are also known to be O-GlcNAc modified (Tables S1 and
S2). Analysis of known O-GlcNAc modification sites in various
proteins revealed that proline at 2/+1 and/or 2/+3 position
from O-GlcNAc site(s) is the most favored residue for O-GlcNAc
modification in a protein (Table S1). Therefore, to increase the
possibility of finding clues for a potential interaction between O-
GlcNAc modification and tyrosine phosphorylation within a
protein, only those proteins were considered which met one of
the following two sets of selection criteria: (i) having potential
tyrosine phosphorylation site(s) in the close proximity of a known
O-GlcNAc site(s) with proline residue(s) at 2/+1 and/or 2/+3
position of O-GlcNAc site(s) or (ii) having potential O-GlcNAc
site(s) with proline residue(s) at 2/+1 and/or 2/+3 position in the
close proximity of a known tyrosine phosphorylation site (in this
category only those proteins were considered which are known to
undergo O-GlcNAc modification however exact sites of modifica-
tion are not known yet). A number of proteins were identified
using each selection criteria (Tables S1 and S2) with strong
association between these two modifications suggesting a potential
interaction between these two dynamic modifications in many
proteins (Table S3). Experiments are currently underway to
further validate this hypothesis.
Discussion
We provide evidence that PHB interacts with OGT in response
to insulin and undergoes O-GlcNAc modification (Fig. 1). O-
GlcNAc modification of PHB was further confirmed by metabolic
labeling with GlcNAz sugar (tetraacetylated azide-modified N-
acetylglucosamine) in C2C12 and NIH-3T3 cell lines (Fig. 1D).
The acetyl groups improve cell-permeability of the azido-sugars
and are removed by non-specific carboxyl esterases before sugars
are incorporated into biosynthetic pathway.
Prediction of potential O-GlcNAc modification sites in PHB on
the basis of known O-GlcNAc sites in several other proteins (Table
S1) identified Ser101 (Proline at +3 position), Ser121 (Proline at
21 position) and Thr258 (Proline at +3 position) as potential O-
GlcNAc modification sites (Fig. 4A). Interestingly, out of four
tyrosine residues present in PHB, one of them (Tyr259) is adjacent
to Thr258 within O-GlcNAc motif (
258TYLP
261) and second
(Tyr114) is flanked by two other potential O-GlcNAc modification
sites i.e. Ser101 (
101SQLP
104) and Ser121 (
120PSITT
124) (Fig. 4A).
Figure 1. PHB interacts with OGT and is O-GlcNAc modified. (A) showing co-immunoprecipitation of PHB and OGT with each other. PHB and
OGT co-immunoprecipitated from RINm5F cells with (100 nM) or without insulin treatment and immunoprecipitates were analyzed by
immunoblotting using respective antibodies (left panel). In (B), in situ colocalization of PHB (green) and OGT (red) is shown in RINm5F cells by
confocal microscopy. Cells were first incubated with rabbit anti-PHB (1:100) and mouse anti-OGT (1:500) antibodies and subsequently detected by
FITC- and TRITC-conjugated secondary antibodies respectively. In (C), left panel showing anti-O-GlcNAc and anti-PHB immunoblots showing
endogenous (__c) and recombinant PHB (c)a sa nO-GlcNAc modified protein. In the right panel same is shown after immunoprecipitation with anti-
PHB antibody. In (D) O-GlcNAc metabolic labeling of PHB by GlcNAz sugar is shown. Cells were grown in the presence of azido-sugar for 72 hrs and
then treated with or without insulin (100 nM). Subsequently azido sugar labeled proteins were ligated with biotin alkene and PHB was
immunoprecipitated using anti-PHB antibody. Immunoprepitates were analyzed by gel-electrophoresis and immunoblotting using streptavidin-HRP
conjugate and anti-PHB antibody. Representative blots of three or more experiments are shown. (Pr - primary, Pro-A - protein-A; IP -
immunoprecipitation, Stvn-HRP - streptavidin horse radish peroxidase; GlcNAz - tetraacetylated azide-modified N-acetylglucosamine).
doi:10.1371/journal.pone.0004586.g001
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PLoS ONE | www.plosone.org 4 February 2009 | Volume 4 | Issue 2 | e4586Figure 2. Interaction between O-GlcNAc modification and tyrosine phosphorylation of PHB. In (A) showing in vitro phosphorylation (left
panel) and O-GlcNAc modification of PHB peptides (right panel) using insulin receptor and immunoprecipitated OGT respectively. In (B) effect of
tyrosine phosphorylation on O-GlcNAc modification and vice versa are shown. To determine the effect of tyrosine phosphorylation on O-GlcNAc
modification, PHB control peptides and phosphate blocked Tyr114 and Tyr259 containing peptides were incubated with OGT and UDP-GlcNAc and
subsequently analyzed by gel-electrophoresis and immunoblotting as described in Methods (right panel). To determine the effect of O-GlcNAc
modification on tyrosine phosphorylation, biotinylated-PHB peptides were first immobilized on streptavidin-agarose and then used for in vitro O-
GlcNAc assays using OGT and UDP-GlcNAc. After washing (36) in reaction buffer same peptides were used for in vitro kinase assays using catalytic
domain of insulin receptor and ATP. Finally, peptides were analyzed by gel-electrophoresis and immunoblotting using anti-phospho tyrosine (left
panel). (C and D) Effect of PHB mutants on tyrosine phosphorylation and O-GlcNAc modification of PHB are shown. PHB and OGT were
immunoprecipitated from insulin (100 nM for 20 mts) treated RINm5F cells after 72 hrs of co-transfection with OGT and PHB/PHB mutants (Y114F,
S121A, T258I and Y259F). Immunoprecipitates were analyzed with gel-electrophoresis and immunoblotting using anti-phosphotyrosine and anti-O-
GlacNAc monoclonal antibodies. Representative blots of three or more experiments are shown. (Pep I - peptide I - pep II, peptide II, IR - insulin
receptor, P - with phosphate group attached to tyrosine, NP - without phosphate group, IP - immunoprecipitation, pY - phosphotyrosine).
doi:10.1371/journal.pone.0004586.g002
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PLoS ONE | www.plosone.org 5 February 2009 | Volume 4 | Issue 2 | e4586Figure 3. Enhanced tyrosine phosphorylation of OGT and OGT activity in cells transfected with PHB mutants (Y114F and Y259F) in
response to insulin. (A) Effect of PHB/PHB mutant constructs on O-GlcNAc modification of various proteins in response to insulin in RINm5F cells is
shown. In (B), cells were transfected with various PHB vectors and subsequently treated with or without insulin. OGT was immunoprecipitated using anti-
OGTantibody andanalyzedusinganti-O-GlcNAcandanti-OGTantibodies.(C)RINm5Fcellswereco-transfectedwithOGTandPHBconstructs.After48 hrs
serum starved cells were treated with insulin (100 nM) for 20 minutes. OGT was immunoprecipiataed using anti-OGT antibody and divided into two
halves. One half was used for immunoblotting using anti-phospho tyrosine antibody (left panel). Another half was used for in vitro O-GlcNAc assay using
PHB synthetic peptide II as a substrate and UDP-GlcNAc. Modified substrate was analyzed by immunoblotting using anti-OGT antibody. Subsequently
immunoblots were analyzed by densitometry using NIH image analysis software. Normalized OGT activity is shown in the lower panel. Representative
blots of three or more experiments are shown. Experiments were repeated for three times. (IP - immunoprecipitation, pY - phosphotyrosine).
doi:10.1371/journal.pone.0004586.g003
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O-GlcNAc modification sites by OGT (Fig. 2A) suggested that it
could be O-GlcNAc sites in vivo too. Subsequently this is confirmed
by site-directed mutagenesis and immunoblotting. Recently PHB
homologue PHB2 was identified as O-GlcNAc modified protein in
stress granules and it has been shown that O-GlcNAc modification
is required for aggregation of untranslated mRNA into stress
granules [22]. Out of two O-GlcNAc modification sites we have
identified in PHB, Ser121 is conserved in PHB2 and correspond-
ing residue in PHB2 is Ser135. Interestingly neighboring tyrosine
residue (Tyr114) in PHB is also conserved in PHB2 and
corresponding residue in PHB2 is Tyr128. Tyr128 in PHB2 has
been identified as phosphorylation site during phospho-tyrosine
profiling in cancer cells [23]. It would be interesting to know
whether O-GlcNAc modification in PHB2 occurs at Ser135. It is
possible that O-GlcNAc modification and tyrosine phosphorylation
in PHB2 interact in the same way as in PHB.
In another study, PHB has been identified as a substrate for Akt
however exact phosphorylation site remains to be determined
[24]. Akt phosphorylates many proteins at serine/threonine
residues that lie in Arg–Xaa–Arg–Xaa–Xaa–Ser/Thr motifs
(where Xaa is any amino acid) and this motif is crucial for the
Figure 4. PHB and OGT family members contain similar tyrosine motifs. Multiple sequence alignments of PHB with OGT family members, as
well as tyrosine motifs of PHB containing Tyr114 and Tyr259 with various OGT family members having similar motifs are shown. (A) showing
sequence homology of human PHB with GlcNAc13, 4GalNT2, human OGT and Oryza OGT. Potential sites of tyrosine phosphorylation (*), O-GlcNAc
modification (#) and proline residues (.)a t21 and/or +3 position from potential O-GlcNAc sites are shown. Multiple serine/threonine residues in
the vicinity of potential O-GlcNAc sites are shown in the box (%). (B) showing motif containing Tyr114, and (C) showing motif containing Tyr259 in
PHB. Conserved residues are shown in red and identical residues are shown in blue. (GlcNAc13 - UDP-N-acetyl-alpha-D-galactosamine: polypeptide N-
acetylgalactosaminyltransferase 13, 4GalNT2 – b-1,4-N-acetyl-galactosaminyl transferase 2).
doi:10.1371/journal.pone.0004586.g004
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one potential motif
254RSRNIT
258 (R-x-R-x-x-S/T) for Akt.
Interestingly Tyr259 in PHB is present at tandem position from
Akt motif and Thr258 O-GlcNAc site is part of Akt consensus
motif (R-x-R-x-x-S/T). This would imply that Thr258 may be
subjected to O-GlcNAc modification or phosphorylation under
different conditions and phosphorylation status of adjacent
tyrosine residue (Tyr259) may play a regulatory role in this
process.
Because PHB (as well as few other insulin signaling interme-
diates such as IRS, Akt, GLUT4 etc) undergoes both O-GlcNAc
modification and tyrosine phosphorylation and these modification
sites are either adjacent or in the close proximity to each other we
hypothesize that O-GlcNAc modification and tyrosine phosphor-
ylation may be a previously unidentified novel binary switch. This
would imply that these modifications may interact and regulate
each other under different conditions, provide read-out for
different interacting partners, attribute multiple functions to the
same protein and may play an important role in cell signaling
cascades (Fig. 5). Using biotinylated peptides spanning potential O-
GlcNAc modification and tyrosine phosphorylation sites we
showed that they indeed affect each other (Fig. 2B). This is
further confirmed in vivo by substituting tyrosine phosphorylation
and O-GlcNAc modification sites by site-directed mutagenesis
(Fig. 2C–D). In addition, an up regulation of O-GlcNAc
modification of some proteins was observed in the absence of
tyrosine phosphorylation sites in PHB in response to insulin (Fig. 2).
Because PHB and OGT both interacts with insulin receptor,
undergoes tyrosine phosphorylation and contain similar tyrosine
motifs it is possible that they may be part of a protein complex
which may also include kinases and phosphatases, and under such
condition loss of a competitive tyrosine phosphorylation sites in
PHB may affect tyrosine phosphorylation and activity of OGT.
Indeed this is exactly what we found in our case and is consistent
with recent report by Whelan et al (2008). However, both OGT
and PHB contain similar phospho tyrosine motifs therefore
recruitment and subsequent modulation by other phospho tyrosine
binding (PTB) domain containing proteins cannot be ruled out
and warrant further investigation.
Using two stringent selection criteria (as discussed above) a
number of proteins were identified with potential tyrosine
phosphorylation sites in the proximity of known O-GlcNAc sites
or vice versa (Table S1 and S2). In both cases, a strong association
was found between presence of proline residues with O-GlcNAc
site (59–93%), as well as O-GlcNAc and tyrosine phosphorylation
sites (71–87%) (Table S3). Given the fact that our knowledge
regarding O-GlcNAc sites in various proteins are very limited, this
high degree of association between O-GlcNAc modification and
tyrosine phosphorylation in various proteins suggests a functional
link between these two dynamic modifications in the regulation of
various cellular events. We speculate that presence of multiple
proline residues around O-GlcNAc/phospho tyrosine cassette play
an important role not only in O-GlcNAc modification but also in
the recruitment of various interacting partners especially proteins/
protein domains which are known to bind phosphorylated residues
adjacent to proline residues. In addition, phosphorylation status of
tyrosine may play a regulatory role in the cross-talk between
serine/threonine phosphorylation and O-GlcNAc modification.
This study offers a novel mechanistic insight in cell signaling
pathways.
Materials and Methods
Cell culture, site directed mutagenesis and transfection
For all cell based experiments cells were grown in 100 mm
culture dish in RPMI-1640 (ATCC, USA) complete growth media
containing 10% FBS, 1% antibiotic-antimycotic at 37uC. OGT
construct was obtained from Prof. Gerald Hart, University of John
Hopkins. The pCMV6-XL5 vector containing human PHB clone
(Reference sequence XM_056688) was obtained from Origene
technologies, USA. PHB mutants were made using site-directed
mutagenesis kit (Stratagene, USA) following manufacturer’s
instructions. The following primers were used for generating
PHB mutants: Y114F, Forward - 59 CAGCATCGGAGAG-
GACTTTGATGAGCGTGTGC 39 and reverse - 59 GCA-
CACGCTCATCAAAGTCCTCTCCGATGCTG 39; Y259F:
Forward -59 TCTCGGAACATCACCTTCCTGCCAGCGG 39
and reverse - 59 CCGCTGGCAGGAAGGTGATGTTCC-
GAGA 39; S121A Forward - 59 AGCGTGTGCTGCCGGC-
CATCACAACTGAG 39 and reverse - 59 CTCAGTTGT-
GATGGCCGGCAGCACACGCT 39; T258I Forward - 59
CTCTCGGAACATCATCTACCTGCCAGCGG 39 and reverse
-5 9 CCGCTGGCAGGTAGATGATGTTCCGAGAG 39. Au-
thenticity of all constructs was confirmed by DNA sequencing at
Cancer Care Manitoba. Transfections were performed using
lipofectamine (Invitrogen, USA), according to manufacturer’s
protocol. After 48 hrs of transfection cells were serum starved and
treated with insulin (100 nM) for 20 minutes. Cell lysates were
prepared in lysis buffer (50 mM Tris-Cl, pH 7.4) containing
protease and phosphatase inhibitors [26] and subsequently
processed for immunoprecipitation using specific antibodies as
described below.
Recombinant protein and peptides
Recombinant human His-tagged PHB (His-PHB) expressed in
Escherichia coliandpurified byHis-affinitycolumn wasobtained from
AmProx Inc. (Carlsbad, CA, USA). Custom made PHB
105–123
Figure 5. O-GlcNAc modification and tyrosine phosphorylation
binary switch. Schematic diagram showing O-GlcNAc modifications at
serine/threonine residues and tyrosine phosphorylation at neighboring
tyrosine residues can potentially regulate each other in a binary fashion
and subsequently may regulate interaction with different partners or
attribute multiple functions to proteins (O - serine/threonine, Y –
tyrosine, G - O-GlcNAc, P – phosphorylation, TK - tyrosine kinase, Pase -
phosphatase, OGT - O-GlcNAc transferase, ONase - O-GlcNAcase).
doi:10.1371/journal.pone.0004586.g005
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250–268 peptides (Pep I and Pep II) were chemically
synthesized as 19mer peptide amidated at C-terminus and
biotinylated at N-terminus. The correct peptides were obtained in
greater than 90% yield and were homogeneous after purification as
confirmed by mass and analytical HPLC.
Immunoprecipitation and Western blot
Immunoprecipitation of PHB and OGT was performed using
Dynabeads Protein A and DynaMag (Invitrogen, USA) according
to manufacturer’s protocol. In brief, to 1 ml of cell lysate (adjusted
for equal amount of protein), 10 ml of rabbit polyclonal anti-PHB
antibody or monoclonal OGT antibody were added and
incubated overnight on a rotating device at 4uC. At the end of
the incubation, 25 ml of Dynabeads protein A suspension were
added to each tube and further incubated for 2 h. Subsequently,
pellets were washed (56) in ice cold PBS, resuspended and used for
in vitro assays and Western blot. Immunoprecipitated proteins
were separated on 12% SDS-PAGE and transferred to nitrocel-
lulose membrane for Western blotting as described earlier [26].
Confocal microscopy
RINm5F cells were cultured in chambered slides, fixed with 4%
formaldehyde in PBS and incubated with antibodies to OGT
(Santa Cruz Biotechnology, USA), and PHB (Cell Signaling, USA)
at a concentration of 1 mg/ml in PBS containing 0.1% BSA.
Immune complexes were detected with TRITC and FITC
conjugated antibodies to mice and rabbit (Sigma, Oakville, ON)
respectively.
O-GlcNAc metabolic labeling of PHB
O-GlcNAc metabolic labeling was performed using Click-iT
GlcNAz metabolic glycoprotein labeling reagent (tetraacetylated
N-azidoacetylgalactosamine and glucosamine) from Invitrogen,
USA. In brief, cultures were seeded at 2.5610
5 cells/ml in
100 mm tissue culture dish and allowed to grow for 72 hrs in the
presence of 40 mM tetraacetylated azido-sugar. Cell lysates were
prepared with or without insulin treatment in lysis buffer (1%
SDS, 50 mM Tris-HCl, pH 8.0) containing protease and
phosphatase inhibitors [26]. PHB was immunoprecipitated using
rabbit anti-PHB antibody (Cell Signaling, USA) and Dynabeads
Protein A (Invitrogen, USA) and subsequently analyzed with
Click-iT Protein Analysis Detection Kit (Invitrogen, USA)
according to manufacturer’s protocol.
In vitro phosphorylation assay
PHB synthetic peptides (2 mg) (Pep I - Biotin-
105RIFTSIGE-
DYDERVLPSIT
123-NH2 and Pep II - Biotin-
250QLSRSRNI-
TYLPAGQSVLL
268-NH2, amidated at C-terminus and biotiny-
lated at N-terminus) were incubated with 20 ng of recombinant
active insulin receptor in kinase buffer (50 mM Tris-HCl, pH 7.5,
10 mM MgCl2, 50 mM ATP) for 20 min at 30uC. At the end of
assays, 10 ml of loading buffer was added to each tube and
analyzed on 16% SDS-PAGE, transferred to nitrocellulose
membranes and processed for Western blot as described above.
To study the effect of O-GlcNAc modification on tyrosine
phosphorylation peptides were first immobilized on streptavidin-
agarose and then processed for in vitro O-glycosylation assay using
immunoprecipitated OGT and UDP-GlcNAc. At the end of
incubation, tubes were transferred to the ice and subsequently
washed (36) to remove reaction mixture and finally resuspended
in 50 mM Tris-Cl buffer pH 7.4 for subsequent use in an in vitro
kinase assay using catalytic domain of insulin receptor and ATP.
Subsequently peptides were analyzed by gel-electrophoresis and
Western blotting as described previously [27].
In vitro O-GlcNAc assays
PHB peptides (Pep I and Pep II) containing Ser121 and Thr258
were incubated with immunoprecipitated OGT in assay buffer
(0.50 mM Na-Cacylodate pH 6.5, UDP-GlcNAc, 0.250 mM
NaF) in a total reaction volume of 40 ml for 2 h at 30uC [15].
Reaction was stopped by adding 10 ml of SDS-PAGE loading
buffer and subsequently analyzed with gel-electrophoresis and
immunoblotting using monoclonal anti–O-GlcNAc antibody. In
some cases, biotinylated peptides were immobilized on streptavi-
din-agarose and subsequently used for in vitro assay as described
above.
Supporting Information
Table S1 Protein sequences having potential tyrosine phosphor-
ylation site in the vicinity of known O-GlcNAc site.
Found at: doi:10.1371/journal.pone.0004586.s001 (0.09 MB
PDF)
Table S2 Protein sequences having potential O-GlcNAc site in
the vicinity of known tyrosine phosphorylation known.
Found at: doi:10.1371/journal.pone.0004586.s002 (0.12 MB
PDF)
Table S3 Summary of potential O-GlcNAc and phospho
tyrosine binary switch.
Found at: doi:10.1371/journal.pone.0004586.s003 (0.14 MB
PDF)
Acknowledgments
We thank Dr. Gregoire Nyomba for critical reading of the manuscript and
Dr. Gerald W. Hart for generous gift of OGT construct.
Author Contributions
Conceived and designed the experiments: SRA SM. Performed the
experiments: SRA SM SM. Analyzed the data: SRA SM. Wrote the paper:
SM.
References
1. Mishra S, Murphy LC, Murphy LJ (2006) The Prohibitins: Emerging roles in
diverse functions. J Cell Mol Med 10: 353–363.
2. Terashima M, Kim KM, Adachi T, Nielsen PJ, Reth M, et al. (1994) The IgM
antigen receptor of B lymphocytes is associated with prohibitin and a prohibitin-
related protein. EMBO J 13: 3782–3792.
3. Sharma A, Qadri A (2004) Vi polysaccharide of Salmonella typhi targets the
prohibitin family of molecules in intestinal epithelial cells and suppresses early
inflammatory responses. Proc Natl Acad Sci USA 101: 17492–17497.
4. Wang P, Mariman E, Keijer J, Bouwman F, Noben JP, et al. (2004) Profiling of
the secreted proteins during 3T3-L1 adipocyte differentiation leads to the
identification of novel adipokines. Cell Mol Life Sci 61: 2405–2417.
5. Kolonin MG, Saha PK, Chan L, Pasqualini R, Arap W (2004) Reversal of
obesity by targeted ablation of adipose tissue. Nat Med 10: 625–632.
6. Bickel PE (2002) Lipid rafts and insulin signaling. Am J Physiol Endocrinol
Metab 282: E1–E10.
7. Mielenz D, Vettermann C, Hampel M, Lang C, Avramidou A, et al. (2005)
Lipid rafts associate with intracellular B cell receptors and exhibit a B cell stage-
specific protein composition1. J Immunol 174: 3508–3517.
8. Ikonen E, Vainio S (2005) Lipid microdomains and insulin resistance: is there a
connection? Sci STKE 268: pe3.
9. Rajalingam K, Wunder C, Brinkmann V, Churin Y, Hekman M, et al. (2005)
Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial
cell migration. Nat Cell Biol 8: 837–43.
10. Law DA, Nannizzi-Alaimo L, Phillips DR (1996) Outside-in integrin signal
transduction aIIbb3-(GP IIb-IIIa) Tyrosine phoshphorylation induced by
platelet aggragation. J Biol Chem 271: 10811–10815.
PHB Interacts with OGT
PLoS ONE | www.plosone.org 9 February 2009 | Volume 4 | Issue 2 | e458611. Xi X, Flevaris P, Stojanovic A, Chishti A, Phillips DR, et al. (2006) Tyrosine
phosphorylation of the integrin beta 3 subunit regulates beta 3 cleavage by
calpain. J Biol Chem 281: 29426–30.
12. Ravetch JV, Lanier LL (2000) Immune inhibitory receptors. Science 290: 84–9.
13. van der Geer P, Pawson T (1995) The PTB domain: a new protein module
implicated in signal transduction. Trends Biochem Sci 20: 277–280.
14. Songyang Z, Margolis B, Chaudhuri M, Shoelson SE, Cantley LC (1995) The
phosphotyrosine interaction domain of SHC recognizes tyrosine-phosphorylated
NPXY motif. J Biol Chem 270: 14863–14866.
15. Whelan SA, Lane MD, Hart GW (2008) Regulation of the O-linked beta-N-
acetylglucosamine transferase by insulin signaling. J Biol Chem 283:
21411–21417.
16. Yang X, Ongusaha PP, Miles PD, Havstad JC, Zhang F, et al. (2008)
Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance.
Nature 451: 964–9.
17. Zachara NE, Hart GW (2006) Cell signaling, the essential role of O-GlcNAc.
Biochim Biophys Acta 1761: 599–617.
18. Wells L, Vosseller K, Hart GW (2001) Glycosylation of nucleocytoplasmic
proteins: signal transduction and O-GlcNAc. Science 291: 2376–8.
19. Slawson C, Lakshmanan T, Knapp S, Hart GW (2008) A mitotic GlcNAcyla-
tion/ phosphorylation signaling complex alters the post-translational state of the
cytoskeletal protein vimentin. Mole Biol Cell Jul 23 [Epub ahead of print,
PMID:18653473].
20. Copeland RJ, Bullen JW, Hart GW (2008) Cross-talk between GlcNAcylation
and phosphorylation: roles in insulin resistance and glucose toxicity. Am J Physiol
Endocrinol Metab 295: E17–28.
21. Mishra S, Nyomba G, Murphy LJ (2007) Insulin induced phosphorylation of
prohibitin at Tyr114 recruits Shp1. Endocrinology Meeting; Abstract # P3-536.
22. Ohn T, Kedersha N, Hickman T, Tisdale S, Anderson P (2008) A functional
RNAi screen links O-GlcNAc modification of ribosomal proteins to stress
granule and processing body assembly. Nat Cell Biol 10: 1129–30.
23. Rush J, Moritz A, Lee KA, Guo A, Goss VL, et al. (2005) Immunoaffinity
profiling of tyrosine phosphorylation in cancer cells. Nat Biotech 23: 94–101.
24. Han EK, Mcgonigal T, Butler C, Giranda VL, Luo Y (2008) Characterization of
Akt overexpression in MiaPaCa-2 cells: prohibitin is an Akt substrate both in
vitro and in cells. Anticancer Res 28: 957–63.
25. Cohen P (2006) The twentieth century struggle to decipher insulin signaling. Nat
Rev Mole Cell Biol 7: 867–73.
26. Mishra S, Melino G, Murphy LJ (2007) Transglutaminase 2 kinase activity
facilitates protein kinase A induced phosphorylation of retinoblastoma protein.
J Biol Chem 282: 18108–18115.
27. Mishra S, Sleh A, Epsino P, Davie JR, Murphy LJ (2006) Phosphorylation of
histones by tissue transglutaminase. J Biol Chem 281 (2006): 5532–38.
PHB Interacts with OGT
PLoS ONE | www.plosone.org 10 February 2009 | Volume 4 | Issue 2 | e4586